Navigation Links
March of Dimes Awards $250,000 Prize to Scientists Unraveling the Causes of Muscular Dystrophy
Date:5/6/2009

BALTIMORE, May 6 /PRNewswire-USNewswire/ -- Two scientists whose work has led to new and better ways to diagnose and potentially treat muscular dystrophy have been chosen to receive the 2009 March of Dimes Prize in Developmental Biology.

Kevin P. Campbell, Ph.D. and Louis M. Kunkel, Ph.D., share the 2009 March of Dimes Prize for their pioneering work identifying the genes and proteins that cause muscular dystrophy, a disorder in which the muscles progressively degenerate. More than 250,000 Americans are affected by the nine forms of muscular dystrophy and other related neuromuscular disorders. Among this group are facioscapulohumeral muscular dystrophy and limb girdle muscular dystrophy, as well as childhood conditions such as Duchenne and Becker muscular dystrophies and congenital muscular dystrophy.

The March of Dimes Prize is a $250,000 cash award and a silver medal in the design of the Roosevelt dime, in honor of President Franklin Delano Roosevelt, who founded the March of Dimes. The Prize was awarded to Dr. Campbell and Dr. Kunkel at a gala black tie dinner and ceremony at the InterContinental Harbor Court in Baltimore May 3. CBS sportscaster Greg Gumbel, member of the March of Dimes national Honorary Board of Trustees, hosted the ceremony.

"Dr. Campbell and Dr. Kunkel have provided crucial insights into how muscular dystrophies develop -- the critical step needed to develop diagnostic tools and potential treatments," said Michael Katz, MD, senior vice president for Research and Global Programs at the March of Dimes.

"Based on their pioneering research, physicians all over the world now are better able to help families and children affected by these disorders. Currently, there are several promising clinical trials of new treatments in progress based on the achievements of these two scientists," Dr. Katz continued.

Dr. Campbell, a Howard Hughes Medical Institute investigator, is professor and head of Molecular Physiology and Biophysics at the University of Iowa Roy J. and Lucille A. Carver College of Medicine. He is also the Roy J. Carver Chair of Molecular Physiology and Biophysics and Director of the Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center. His work unraveled the molecular mechanisms of muscular dystrophies.

Dr. Kunkel, also a Howard Hughes Medical Investigator, is professor of Pediatrics and Genetics at Harvard Medical School as well as Director of the Program in Genomics at The Children's Hospital in Boston, Massachusetts. More than 20 years ago, Dr. Kunkel identified dystrophin, the gene encoding the protein that is altered in boys with Duchenne and Becker forms of muscular dystrophy.

The March of Dimes Prize in Developmental Biology has been awarded annually since 1996 to investigators whose research has profoundly advanced the science that underlies the understanding of birth defects. The March of Dimes Foundation created the Prize as a tribute to Dr. Jonas Salk, who received Foundation support for his work to create a polio vaccine.

Also on May 3, Dr. Campbell and Dr. Kunkel delivered the Fourteenth Annual March of Dimes Prize Lectures at the Baltimore Convention Center during the 2009 Annual Meeting of the Pediatric Academic Societies.

The March of Dimes is the leading nonprofit organization for pregnancy and baby health. With chapters nationwide and its premier event, March for Babies(R), the March of Dimes works to improve the health of babies by preventing birth defects, premature birth and infant mortality. For the latest resources and information, visit marchofdimes.com or nacersano.org.


'/>"/>
SOURCE March of Dimes
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Martha Reeves to Participate in the National Federation of the Blind Motor City March for Independence
2. HealthSouth Reports Strong EPS Results for First Quarter Ended March 31, 2009
3. Airport Workers March and Rally to Call for Family Healthcare as Swine Flu Fears Mount
4. Young Innovations, Inc. Announces Results for the Quarter Ended March 31, 2009
5. For Mothers Day, Show Your Love By Helping the March of Dimes Help All Moms Have Healthy Babies
6. Farmers Insurance Joins March of Dimes March for Babies April 25, 2009
7. Boston Scientific Announces Results For First Quarter Ended March 31, 2009
8. Stryker Operating Results for Quarter Ended March 31, 2009
9. University of Phoenix Announces March of Dimes Partnership in Florida, Offers Four Full-Tuition Nursing Scholarships
10. Hollywood Moms Team Up For March For Babies
11. Martek, March of Dimes Partner to Promote Importance of DHA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2017)... , ... January 22, 2017 , ... Medical lab ... results. Often the results of a simple test will take days to arrive to ... Test Now offers customers direct access to their lab tests, bypassing the cost and ...
(Date:1/21/2017)... ... January 21, 2017 , ... Salveo for life, a ... bringing its product to the United States as part of its presence to expand ... years, Alcovit aims to reduce the productions of nasty toxins as a result of ...
(Date:1/21/2017)... ... January 21, 2017 , ... Seamild, the largest manufacturer of oats in China, ... owner and founder. As Oat is recognized globally as one of the healthiest cereals, ... he believes it is a move to sow the seed of good karma. Buddhism ...
(Date:1/21/2017)... ... January 21, 2017 , ... Pacifica ... Travis-Teague, the electrifying line-up of events for its annual meeting “Coming Home 2017,” ... community. “Coming Home 2017” will be held on Friday January 27 through ...
(Date:1/21/2017)... ... January 21, 2017 , ... ... medical office in Petaluma, located at 167 Lynch Creek Way. The Petaluma office ... SRO sports medicine and rehabilitation services and on-site x-ray services. Two multi-specialist ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017 Report Details ... Alzheimer,s Disease ... Companies – our new study reveals trends, R&D progress, ... events affecting the Alzheimer,s disease therapeutics and diagnostics market. ... key questions: - How is the Alzheimer,s disease therapeutics ...
(Date:1/19/2017)... Jan. 19, 2017  Stealth BioTherapeutics Inc. ( Stealth ... mitochondrial dysfunction, today announced new additions to its senior ... Chief Medical Officer, and Daniel Geffken as ... Jim Carr , Pharm.D. has been promoted to ... pleased to welcome Doug and Daniel to our management ...
(Date:1/19/2017)... , Jan. 19, 2017 Accuray Incorporated (Nasdaq: ... and TomoTherapy® Systems continue to set the bar for ... highest composite overall user satisfaction rating among radiation treatment ... 2016 MD Buyline Market Intelligence Briefing™. The most recent ... composite ratings among industry peers for 11 of the ...
Breaking Medicine Technology: